Gary H. Gibbons

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

Heiko E. von der Leyen, Gary H. Gibbons, Ryuichi Morishita et al. · Proceedings of the National Academy of Sciences · 1995 · 768 citations · Full text

Medicine, Molecular Biology, Molecular Medicine +17

Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

Gary H. Gibbons, Richard E. Pratt, Victor J. Dzau · Journal of Clinical Investigation · 1992 · 645 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

Ryuichi Morishita, Gary H. Gibbons, Masatsugu Horiuchi et al. · Proceedings of the National Academy of Sciences · 1995 · 482 citations · Full text

Medicine, Genetics, Molecular Biology +15

Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

Hiroaki Itoh, Masashi Mukoyama, R E Pratt et al. · Journal of Clinical Investigation · 1993 · 466 citations · Full text

Life Sciences, Cell Biology, Cell Proliferation +13

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.

Ryuichi Morishita, Gary H. Gibbons, Kristin Ellison et al. · Proceedings of the National Academy of Sciences · 1993 · 458 citations

Pharmacy, Cardiology, Molecular Medicine +13